Colchicine for treatment of acute or recurrent pericarditis
In The Lancet, Massimo Imazio and colleagues report on the Colchicine for Recurrent Pericarditis 2 (CORP-2) trial for treatment of multiple recurrences of pericarditis. This study answers one of the last questions about the role of colchicine for the treatment of pericarditis. The findings should he...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2014-06, Vol.383 (9936), p.2193-2194 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In The Lancet, Massimo Imazio and colleagues report on the Colchicine for Recurrent Pericarditis 2 (CORP-2) trial for treatment of multiple recurrences of pericarditis. This study answers one of the last questions about the role of colchicine for the treatment of pericarditis. The findings should help convince clinicians of the major role of colchicine in the treatment of patients with either acute or recurrent (even multiple) pericarditis, and should change clinical practice. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(14)60113-6 |